The World Health Organization is seeking answers from Russia over the death of a 28-year-old laboratory worker who developed severe pneumonia while employed at an institute that researches plague and other dangerous pathogens, with the cause of death still unconfirmed.
The worker was based at the Irkutsk Anti-Plague Research Institute, established in 1934, which studies plague alongside pathogens including anthrax and cholera and is rumoured to be connected to biological weapons research. She died on 2 October.
Writing in a Guardian opinion column, Prof Devi Sridhar, chair of global public health at the University of Edinburgh, said the case has drawn global headlines because of the lack of transparency from Russian authorities and ongoing concerns about biological weapons programmes.
Prof Ashish Jha, the former US White House Covid-19 response coordinator who co-chaired an Ebola commission with Sridhar, wrote on social media that US intelligence assesses Russian scientists are continuing to develop biological weapons capabilities, noting that those programmes operate in secret, that nobody outside inspects them and that nobody inside has much incentive to admit when something goes wrong.
Initial coverage in local media suggested the worker died of pneumonic plague following a laboratory accident, possibly involving a broken test tube.
Pneumonic plague is caused by the bacterium Yersinia pestis and can spread through respiratory contact. It is always fatal if untreated, although it is largely treatable when antibiotics are given within 24 hours of symptoms appearing, or before onset following exposure. It is a different disease from the more common bubonic plague, which transmits through flea bites.
Russian health authorities denied the death was a case of plague, describing it instead as pneumonia of unknown origin, but moved quickly to place about 200 contacts of the worker under quarantine. Authorities reported that no high-threat pathogens had been detected and that monitoring had ended. The WHO released a statement noting a potential second linked case, which Russia denied.
The WHO has asked the Russian government to confirm the diagnosis, provide details of the investigations and explain why so many people were quarantined, as well as to share more information on the second case. It has not yet received that information.
Sridhar notes that if the infection had been spreading, additional cases would likely have emerged by now. The worker died on 2 October, and the testing of contacts and the release of those in quarantine indicate any spread has so far been contained. She adds that continued monitoring is important because the incubation period can run from one to three days.
Assuming the illness was pneumonic plague, Sridhar outlines three hypothetical scenarios. In the first, the worker was exposed to the bacterium accidentally during research and either did not know or did not tell anyone out of fear, so she did not seek treatment immediately and her treatment window was missed.
In the second, the worker was exposed to an antibiotic-resistant strain. Sridhar acknowledges this may sound like a conspiracy theory, but notes that senior academics have raised concerns given the history of the Soviet biological weapons programme and the potential for pathogens to be engineered for hostile purposes.
In the third, Dan Singer, the former White House director for countering biological threats, suggested the worker may have been given an outdated vaccine that is available only in Russia and is not approved by the WHO or most other countries. This live-attenuated vaccine uses a weakened version of the bacteria, does not always provide protection and can sometimes cause disease.
Sridhar writes that insufficient information from the Russian authorities means what happened is unknown. Investigators would need access to laboratory and clinical evidence, including genomic sequencing, pathogen identification and details of the worker’s research. Without it, speculation stands in place of the scientific certainty required.
As a WHO member, Russia has an international legal obligation to share information with the agency. The WHO’s health regulations cover “unusual and unexpected” events, as well as those with serious public health impact and a significant risk of international spread, or a risk of affecting trade or travel. Sridhar notes there is no real enforcement mechanism, and the system relies on broad cooperation between countries on the understanding that sharing information on disease spread is in every nation’s best interest.
The US government has also put pressure on Russia for answers, with Donald Trump saying he would speak to Putin about the situation. The US state department also formally requested further information under the international health regulations. Sridhar highlights the irony that the US withdrew from the WHO in January 2026 but is now invoking the international framework it left behind.
Sridhar concludes that no advances in diagnostics, genomic sequencing, vaccines or accessible treatments can compensate for a failure to share the information needed to identify a pathogen in the first place, describing preparedness as a political challenge as well as a scientific one.
COMMENTS